Meloxicam 7.5mg Tablet Franchise in Ahmedabad

Anti-Inflammatory & Analgesic Therapy Supplier in Mumbai

Meloknot 7 Tablet Distributor in Delhi

Arthritis & Joint Pain Tablet Franchise Opportunity in Bangalore

Musculoskeletal Pain Tablet Stockist in Hyderabad
Meloxicam 7.5mg Export & Manufacturing in Chandigarh

Home/Products /meloxicam-7-5mg-tablet

Meloknot 7 Tablet

Composition : Meloxicam (7.5mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Meloknot 7 Tablet contains Meloxicam 7.5mg, a preferential COX-2 inhibiting non-steroidal anti-inflammatory drug (NSAID) indicated for the management of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and musculoskeletal pain. It helps in reducing joint inflammation, stiffness, and pain while improving mobility.

Meloxicam works by inhibiting cyclooxygenase enzymes involved in prostaglandin synthesis, thereby reducing pain and inflammation with a comparatively improved gastrointestinal safety profile. The lower strength makes it suitable for long-term therapy and dose-adjusted treatment plans.

For distributors and healthcare suppliers, Meloknot 7 Tablet is a high-demand anti-inflammatory and analgesic product, commonly prescribed for early-stage arthritis, maintenance therapy, and elderly patients. Consistent use in chronic joint disorders ensures stable market demand.

Adding Meloknot 7 Tablet to your pain management and anti-inflammatory therapy segment creates strong opportunities in pharmacies, hospitals, orthopedic clinics, export markets, and third-party manufacturing. Its balanced efficacy, long-term usability, and strong prescriber confidence make it a valuable addition to pharmaceutical distribution portfolios.

Read More

About the Product

Meloknot 7 Tablet contains Meloxicam 7.5mg, a preferential COX-2 inhibiting non-steroidal anti-inflammatory drug (NSAID) indicated for the management of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and musculoskeletal pain. It helps in reducing joint inflammation, stiffness, and pain while improving mobility.

Meloxicam works by inhibiting cyclooxygenase enzymes involved in prostaglandin synthesis, thereby reducing pain and inflammation with a comparatively improved gastrointestinal safety profile. The lower strength makes it suitable for long-term therapy and dose-adjusted treatment plans.

For distributors and healthcare suppliers, Meloknot 7 Tablet is a high-demand anti-inflammatory and analgesic product, commonly prescribed for early-stage arthritis, maintenance therapy, and elderly patients. Consistent use in chronic joint disorders ensures stable market demand.

Adding Meloknot 7 Tablet to your pain management and anti-inflammatory therapy segment creates strong opportunities in pharmacies, hospitals, orthopedic clinics, export markets, and third-party manufacturing. Its balanced efficacy, long-term usability, and strong prescriber confidence make it a valuable addition to pharmaceutical distribution portfolios.

Common side effects may include nausea, abdominal discomfort, indigestion, diarrhea, dizziness, or headache. Rare but serious side effects include gastrointestinal bleeding, ulcers, kidney impairment, cardiovascular complications, or allergic reactions. Patients should consult a healthcare professional if severe or persistent symptoms occur.

Meloknot 7 Tablet is indicated for the management of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and other inflammatory musculoskeletal conditions. It is also used to relieve mild to moderate pain and inflammation associated with joint disorders.

Before taking Meloknot 7 Tablet, inform your doctor if you have a history of stomach ulcers, gastrointestinal bleeding, heart disease, kidney or liver impairment, or hypersensitivity to NSAIDs. The tablet should be taken as prescribed, preferably with food, and long-term use should be monitored by a healthcare provider.

Store Meloknot 7 Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and ensure the blister pack is intact. Do not use the tablet beyond its expiry date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation